K935138 is an FDA 510(k) clearance for the IMMULITE PROGESTERONE. Classified as Radioimmunoassay, Progesterone (product code JLS), Class I - General Controls.
Submitted by Diagnostic Products Corp. (Los Angeles, US). The FDA issued a Cleared decision on January 11, 1994 after a review of 75 days - a notably fast clearance cycle.
This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1620 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Diagnostic Products Corp. devices